Pelvic Floor Dysfunction(PFD)
Conditions
Interventions
control group:Aerobic exercise: 20 minutes of uniform running training three times a day for three weeks.
Pelvic floor muscle training group:1) Aerobic exercise: 20-minute steady running training three times a day for three weeks
2) Home pelvic floor muscle training: Training frequency is five days a week, three times a day, each time including rapid contraction, sustained contraction and coordination function training, with 2
Localized diagnosis and in-situ treatment technology group:1) Aerobic exercise: Three 20-minute steady running sessions per day for three consecutive weeks.
2) Home pelvic floor muscle training: Five
Sponsors
Women‘s Hospital, School of Medicine, Zhejiang University
Eligibility
Sex/Gender
Female
Age
20 Years to 46 Years
Inclusion criteria
Inclusion criteria: Women between 42 days and 1 year postpartum, regardless of mode of delivery (vaginal or cesarean section); with intact cognitive and memory functions, as well as proficient Mandarin language expression skills; capable of performing basic physical activities or aerobic exercises, including maintaining a steady running pace for more than 30 minutes (at least three times per week for a minimum of one month); diagnosed with mild stress urinary incontinence according to established pelvic floor dysfunction criteria, with a total score of >= 3 on the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI-SF), and experiencing involuntary urinary leakage from the urethral meatus during physical activity or aerobic exercise; willing to participate in clinical observation and having signed the informed consent form.
Exclusion criteria
Exclusion criteria: Being pregnant or planning to become pregnant during the intervention; A history of hysterectomy or pelvic surgery (for urinary incontinence, anal incontinence, or pelvic organ prolapse); A musculoskeletal injury within the past 6 months that negatively affects exercise, and an inability to perform pelvic floor muscle contractions correctly; Patients with serious medical or surgical diseases; Damage, ulceration or infection at the treatment or testing site; Acute infection stage, high fever and coma; Patients with heart, liver and kidney dysfunction; Patients with a history of deep venous thrombosis of the lower extremities; Patients with malignant tumors and other chronic diseases; Vaginal bleeding, vaginitis; History of pelvic radiotherapy; Diseases of the nervous system that significantly affect muscle function; Patients with a history of neurologic or psychiatric problems who were deemed by the investigator to be ineligible for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic floor muscle strength;Fatigue of the pelvic floor muscles;Pelvic floor muscle coordination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary incontinence related questionnaire score; | — |
Countries
China
Contacts
Public ContactXie Zhenwei
Women‘s Hospital, School of Medicine, Zhejiang University
Outcome results
None listed